Phibro Animal Health Corporation reported $1.52B of revenue over the trailing twelve months, +17% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.52B (to Q4 2026). Net income: $100M, trailing twelve months to Q4 2026. Free cash flow: $9.9M, trailing twelve months to Q4 2026. Operating margin: 13%, trailing twelve months to Q4 2026.

PAHCPhibro Animal Health Corporation

Healthcare

$38.29-3.0% 1Y

$38.29

$28.4052 weeks$59.33

PAHC as reported

Phibro Animal Health Corporation reported $1.52B of revenue over the trailing twelve months, +17% on the year before. 11 reported series are charted on this page, each one as filed.

$1.52B

Revenue, trailing twelve months · to Q4 2026 · +17% against the twelve months before

Net income: $100M
Net income · +107% year on year · trailing twelve months to Q4 2026
Free cash flow: $9.9M
Free cash flow · −76% year on year · trailing twelve months to Q4 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for PAHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.52B	+17%	Q4 2026
Net income	$100M	+107%	Q4 2026
EPS	$2.44	+105%	Q4 2026
Gross margin	34%	n/a	Q4 2026
Operating margin	13%	n/a	Q4 2026
Net margin	6.6%	n/a	Q4 2026
ROE	25%	n/a	Q4 2026
ROA	6.2%	n/a	Q4 2026
ROIC	15%	n/a	Q4 2026
Free cash flow	$9.9M	−76%	Q4 2026
P/E	15.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.